Carlsmed (CARL) Non-Current Assets (2024 - 2026)
Carlsmed's (CARL) quarterly Non-Current Assets came in at $8.6 million in Q2 2026, up 21.56% on a YoY basis from $7.1 million in Q2 2025, and up 155.84% quarter-over-quarter from $3.4 million in Q1 2026.
Analysis
Carlsmed (CARL) Non-Current Assets (2024 - 2026) Analysis & Trends
Carlsmed (CARL) has reported Non-Current Assets for 3 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 21.56% year-over-year to $8.6 million; the trailing twelve-month figure through Jun 2026 stood at $18.8 million (changed N/A YoY), and the FY2025 full-year result was $3.4 million, up 39.39% from the prior year.
- Non-Current Assets climbed to $8.6 million in Q2 2026 per CARL's latest filing, from $3.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $8.6 million in Q2 2026 and bottomed at $2.5 million in Q4 2024.
- Historically, Non-Current Assets has averaged $4.7 million across 3 years, with a median of $3.4 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Non-Current Assets jumped 39.39% in 2025, then rose 21.56% in 2026.
- Over 3 years, Non-Current Assets stood at $2.5 million in 2024, then jumped by 39.39% to $3.4 million in 2025, then surged by 149.61% to $8.6 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $8.6 million, $3.4 million, and $3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 4.64 Bn |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | 8.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.60 Mn |
| Mar 31, 2026 | 3.36 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 7.08 Mn |
| Dec 31, 2024 | 2.47 Mn |